Remgro Ltd (REM) Share Price & Latest SENS Announcements

REMGRO LIMITED - Summary of audited results for the year ended 30 June 2026 and cash dividend declarations

Remgro's HEPS of R20.03 meets guidance; the 73% dividend hike is the real news.

REMGRO LIMITED - Trading statement for the year ended 30 June 2026

Remgro guides FY2026 HEPS up 37%–47% to R19.30–R20.71, with underlying growth of 24%–34%.

REMGRO LIMITED - Notice of an acquisition of a beneficial interest in Remgro Limited securities

Ninety One crosses 5% beneficial-interest threshold at 5.0156% — a mandatory ownership disclosure, not an investment signal.

REMGRO LIMITED - Notice of an acquisition of a beneficial interest in Remgro Limited securities

Asset manager Ninety One discloses a 5.0004% holding — routine regulatory filing, no investment signal.

REMGRO LIMITED - Restructuring of interests in Mediclinic Holdings implementation of transaction

Mediclinic restructuring closed 1 July 2026 as announced; terms unchanged from March Category 2 disclosure.

REMGRO LIMITED - Summary of Mediclinic Holdings Limited results for the year ended 31 March 2026

Mediclinic reports a $733m loss on $1.24bn in impairments, despite strong adjusted operating growth.

REMGRO LIMITED - Completion of disposal of shares held in FirstRand Limited

Remgro completed its FirstRand exit, securing R3.59 billion to fund ongoing portfolio restructuring.

REMGRO LIMITED - Dealings in securities by an executive director

Executive director sells R1.24 million in shares following routine vesting of performance awards.

REMGRO LIMITED - Dealings in securities by executive directors, prescribed officers and the company secretary

Routine insider share sales to settle tax liabilities following the vesting of performance awards.